Both in Pharmaceuticals
Enliven Therapeutics vs Arcutis Biotherapeutics
Over the past year ELVN returned +129.1% and ARQT returned +43.7%; their daily moves had a correlation of 0.18.
ELVN +129.1% ARQT +43.7%Growth of $1, one year, split-adjusted
| Metric | ELVN | ARQT |
|---|---|---|
| Price | $46.51 | $26.75 |
| Market cap | $3.41B | $3.36B |
| Today | +1.09% | −2.12% |
| 1 month | −19.6% | +12.5% |
| 6 months | +27.1% | +25.4% |
| Year to date | +202.0% | −7.9% |
| 1 year | +132.4% | +52.2% |
| Revenue growth (YoY) | — | +59.3% |
| Gross margin | — | 91.6% |
| Net margin | — | 11.6% |
| P/E (TTM) | — | 117.9× |
| Price / sales | — | 7.2× |
| Net cash | $895.2M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 39.6% | 46.8% |
| Short % of float | 14.2% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).